tiprankstipranks
Akso Health Group Sponsored ADR (AHG)
NASDAQ:AHG
Holding AHG?
Track your performance easily

Akso Health Group Sponsored ADR (AHG) Income Statement

146 Followers

Akso Health Group Sponsored ADR Income Statement

Last quarter (Q ), Akso Health Group Sponsored ADR's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Akso Health Group Sponsored ADR's net income was $―. See Akso Health Group Sponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
-$ 2.08M$ 13.18M$ 6.00M$ 1.87M$ 8.20M
Credit Losses Provision
----$ 22.16M$ 14.23M
Non Interest Expense
-$ 11.17M$ 27.79M$ 9.21M$ 32.94M$ 50.08M
Incomefrom Associatesand Other Participating Interests
------
Special Income Charges
-$ -2.41M$ -12.25M$ -6.15M$ -4.58M$ -30.27M
Pretax Income
-$ -9.09M$ -13.07M$ -4.01M$ -31.07M$ -46.87M
Tax Provision
-$ 24.99K$ 17.55K$ 92.82K$ 482.98K$ 489.95K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-$ -9.46M$ -1.36M$ -16.85M$ -34.83M$ -66.20M
Basic EPS
-$ -0.07$ -0.04$ -0.56$ -0.71$ -4.38
Diluted EPS
-$ -0.07$ -0.04$ -0.56$ -0.71$ -4.38
Basic Average Shares
-$ 141.52M$ 68.60M$ 59.61M$ 48.84M$ 16.25M
Diluted Average Shares
-$ 141.52M$ 68.60M$ 59.61M$ 48.84M$ 16.25M
Dividend Per Share
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Interest Income After Provision For Loan Loss
-$ 2.67M$ -4.96K$ -804.14K$ -22.16M$ -14.23M
Net Income From Continuing And Discontinued Operation
-$ -9.46M$ -1.36M$ -16.85M$ -34.83M$ -66.20M
Normalized Income
-$ -8.89M$ -10.32M---
Total Money Market Investments
------
Ebit
------
Ebitda
------
Currency in USD

Akso Health Group Sponsored ADR Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis